Commonwealth Equity Services, LLC Oramed Pharmaceuticals Inc. Transaction History

Commonwealth Equity Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $2,300 - $4,955	500 Added 1.69%	30,014 $194,000
Q2 2022 Jul 19, 2022	BUY	$3.72 - $9.0 $7,254 - $17,550	1,950 Added 7.07%	29,514 $135,000
Q1 2022 May 04, 2022	BUY	$8.19 - $13.89 $3,800 - $6,444	464 Added 1.71%	27,564 $238,000
Q3 2021 Oct 29, 2021	BUY	$12.13 - $23.82 $4,852 - $9,528	400 Added 1.5%	27,100 $595,000
Q1 2021 May 04, 2021	BUY	$4.22 - $11.33 $112,674 - $302,511	26,700 New	26,700 $271,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.